 Company to Present Corporate Update During Investor Webcast, April 14, 2022, at 4:30pm ET RADNOR, Pa. , April 8, 2022 PRNewswire -- NRx Pharmaceuticals, Inc. Nasdaq: NRXP NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company, today announced its interim Chief Executive Officer, Robert Besthof, and other executive leaders will be presenting updates to the companys business at the 21st Annual Needham Virtual Healthcare Conference. 